共 266 条
[31]
Leung NW(2009)Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B J Hepatol 51 640-897
[32]
Ghany MG(2004)Cost of chronic hepatitis B infection in China J Clin Gastroenterol 38 S175-528
[33]
Doo EC(2008)The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons Value Health 11 527-251
[34]
Lee JM(2008)Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI) Value Health 11 886-272
[35]
Park JY(2004)Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 7 518-S12
[36]
Kim Do Y(2000)Development of WHO guidelines on generalized cost-effectiveness analysis Health Econ 9 235-283
[37]
Nguyen T(2011)Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis Med Care 49 267-14
[38]
Hong SP(2009)EASL Clinical Practice Guidelines J Hepatol 50 243-8
[39]
Kim SO(2009)National Institutes of Health consensus development conference statement: management of hepatitis B Hepatology 49 S4-76
[40]
Chon CY(2008)Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 263-111